Related Experiment Video

Updated: Jun 17, 2026

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

Drug discovery and assay development in the ubiquitin-proteasome system

Celia R Berkers1, Huib Ovaa

  • 1Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. c.berkers@nki.nl

Biochemical Society Transactions
|January 16, 2010
PubMed

Insights

Proteasome inhibitors like bortezomib show promise in cancer treatment. New strategies are being developed to overcome drug resistance and expand their use for various diseases.

Area of Science:

  • Pharmacology
  • Oncology
  • Immunology

Background:

  • Tumor cells exhibit greater sensitivity to proteasome inhibition than normal cells.
  • Bortezomib is the only approved proteasome inhibitor, demonstrating clinical success.
  • Adverse effects and resistance to bortezomib necessitate the development of new agents.

Purpose of the Study:

  • To discuss novel strategies for overcoming drug resistance to proteasome inhibitors.
  • To explore broadening the application of proteasome inhibitors beyond cancer treatment.
  • To review the development of second-generation proteasome inhibitors and relevant assays.

Main Methods:

  • Review of current literature on proteasome inhibitors.
  • Analysis of strategies to combat drug resistance.
  • Discussion of assays for proteasome inhibition and drug effectiveness.

Main Results:

  • Development of second-generation proteasome inhibitors is underway.
  • Assays are being developed to correlate proteasome inhibition with drug efficacy.
  • New strategies aim to enhance the therapeutic index of proteasome inhibitors.

Conclusions:

  • Overcoming drug resistance is crucial for expanding proteasome inhibitor therapy.
  • Proteasome inhibitors hold potential for treating infectious and autoimmune diseases.
  • Future strategies will focus on personalized medicine approaches for proteasome inhibitor treatment.

More Related Videos

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay07:05

Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay

Published on: September 27, 2024

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...